Six Dean Omar Branham Shirley Partners Honored for Representation of Plaintiffs
Dean Omar Branham Shirley LLP announces six partners named to Lawdragon's 500 Leading Plaintiff Consumer Lawyers for 2025. Partner Jessica Dean secured a $45 million mesothelioma verdict against Johnson & Johnson (NYSE: JNJ) and Kenvue Inc. last year.
Notable achievements include Ben Braly's $22.5 million verdict against R.T. Vanderbilt in an asbestos-related wrongful death suit, and Mark Linder's involvement in a $39 million verdict in the first-ever talc pleurodesis case in Massachusetts. The firm secured at least six multimillion-dollar judgments for plaintiffs in 2024.
The honored partners include Jessica Dean (5th year), Amin Omar (4th year), Trey Branham, Lisa Shirley, Ben Braly, and Mark Linder, recognized for their expertise in personal injury, product liability, asbestos litigation, and appellate practice.
Dean Omar Branham Shirley LLP annuncia sei soci nominati per Lawdragon's 500 Leading Plaintiff Consumer Lawyers per il 2025. La socia Jessica Dean ha ottenuto un verdetto di $45 milioni per mesotelioma contro Johnson & Johnson (NYSE: JNJ) e Kenvue Inc. lo scorso anno.
Tra i risultati notevoli ci sono il verdetto di $22,5 milioni di Ben Braly contro R.T. Vanderbilt in un processo per morte ingiusta legato all'amianto, e il coinvolgimento di Mark Linder in un verdetto di $39 milioni nel primo caso di pleurodesi da talco nel Massachusetts. Lo studio legale ha ottenuto almeno sei sentenze multimilionarie a favore dei ricorrenti nel 2024.
I soci onorati includono Jessica Dean (5° anno), Amin Omar (4° anno), Trey Branham, Lisa Shirley, Ben Braly e Mark Linder, riconosciuti per la loro esperienza in lesioni personali, responsabilità del prodotto, contenzioso sull'amianto e pratica d'appello.
Dean Omar Branham Shirley LLP anuncia seis socios nombrados en Lawdragon's 500 Leading Plaintiff Consumer Lawyers para 2025. La socia Jessica Dean obtuvo un veredicto de $45 millones por mesotelioma contra Johnson & Johnson (NYSE: JNJ) y Kenvue Inc. el año pasado.
Logros notables incluyen el veredicto de $22.5 millones de Ben Braly contra R.T. Vanderbilt en un caso de muerte injusta relacionado con el asbesto, y la participación de Mark Linder en un veredicto de $39 millones en el primer caso de pleurodesis por talco en Massachusetts. La firma aseguró al menos seis fallos multimillonarios para los demandantes en 2024.
Los socios homenajeados incluyen a Jessica Dean (5º año), Amin Omar (4º año), Trey Branham, Lisa Shirley, Ben Braly y Mark Linder, reconocidos por su experiencia en lesiones personales, responsabilidad del producto, litigios sobre asbesto y práctica de apelación.
딘 오마르 브랜햄 셜리 LLP는 2025년 로드래곤의 500대 원고 소비자 변호사에 이름을 올린 여섯 명의 파트너를 발표했습니다. 파트너 제시카 딘은 작년에 존슨앤존슨(NYSE: JNJ)과 켄뷰 주식회사를 상대로 한 $4500만 메소텔리오마 판결을 확보했습니다.
주목할 만한 성과로는 벤 브래리의 R.T. 반더빌트에 대한 $2250만 판결과 마크 린더가 매사추세츠에서 최초의 탈크 흉막비대증 사건에서 $3900만 판결에 연루된 사례가 있습니다. 이 로펌은 2024년 동안 원고를 위해 최소 여섯 건의 수백만 달러 판결을 확보했습니다.
수상한 파트너로는 제시카 딘(5년차), 아민 오마르(4년차), 트레이 브랜햄, 리사 셜리, 벤 브래리, 마크 린더가 있으며, 이들은 개인 상해, 제품 책임, 석면 소송 및 항소 실무에 대한 전문성으로 인정받았습니다.
Dean Omar Branham Shirley LLP annonce six partenaires nommés dans Lawdragon's 500 Leading Plaintiff Consumer Lawyers pour 2025. La partenaire Jessica Dean a obtenu un verdict de 45 millions de dollars pour mésothéliome contre Johnson & Johnson (NYSE: JNJ) et Kenvue Inc. l'année dernière.
Parmi les réalisations notables, on trouve le verdict de 22,5 millions de dollars de Ben Braly contre R.T. Vanderbilt dans une affaire de décès injustifié lié à l'amiante, et l'implication de Mark Linder dans un verdict de 39 millions de dollars dans le tout premier cas de pleurodèse par talc dans le Massachusetts. Le cabinet a obtenu au moins six jugements multimillionnaires en faveur des plaignants en 2024.
Les partenaires honorés incluent Jessica Dean (5e année), Amin Omar (4e année), Trey Branham, Lisa Shirley, Ben Braly et Mark Linder, reconnus pour leur expertise en matière de blessures corporelles, de responsabilité du produit, de contentieux sur l'amiante et de pratique d'appel.
Dean Omar Branham Shirley LLP gibt die Nominierung von sechs Partnern für Lawdragon's 500 Leading Plaintiff Consumer Lawyers für 2025 bekannt. Partnerin Jessica Dean sicherte sich im letzten Jahr ein Urteil über $45 Millionen wegen Mesotheliom gegen Johnson & Johnson (NYSE: JNJ) und Kenvue Inc.
Bemerkenswerte Erfolge umfassen Ben Bralys $22,5 Millionen Urteil gegen R.T. Vanderbilt in einer Klage wegen unrechtmäßigen Todes im Zusammenhang mit Asbest sowie Mark Linders Beteiligung an einem $39 Millionen Urteil im ersten Talc-Pleurodese-Fall in Massachusetts. Die Kanzlei sicherte sich 2024 mindestens sechs Urteile in Millionenhöhe für Kläger.
Die geehrten Partner sind Jessica Dean (5. Jahr), Amin Omar (4. Jahr), Trey Branham, Lisa Shirley, Ben Braly und Mark Linder, die für ihre Expertise in Personenschäden, Produkthaftung, Asbestverfahren und Berufungsverfahren anerkannt wurden.
- Multiple significant legal victories including $45M verdict against Johnson & Johnson
- Secured $22.5M verdict in asbestos-related case against R.T. Vanderbilt
- Won $39M verdict in precedent-setting talc pleurodesis case
- Achieved at least six multimillion-dollar judgments in 2024
- None.
Lawdragon names firm partners to 500 Leading Plaintiff Consumer Lawyers list
The annual listing describes this year’s honorees as “coast-to-coast champions who dedicate their lives to helping people going through the hardest moments of their lives.”
“A special thank you to Lawdragon for including us,” said Mr. Branham, the firm’s managing partner “Our clients go through the most horrific circumstances, and we are honored to be their advocates.”
Ms. Dean celebrates her fifth year on the list. Last year she secured a
Mr. Omar, who is honored for a fourth year, is known for holding large corporations accountable for lapses in safety and for completing successful negotiations. He was cited for excellence in personal injury, product liability and workplace safety.
Mr. Branham, who was recognized for product liability and personal injury work, has spent decades representing plaintiffs in cases against some of the largest corporations in the nation.
Ms. Shirley heads the firm’s motion and appellate practice, and her work has led to important legal precedents for mesothelioma victims. Ms. Shirley is honored for asbestos, appellate, product liability and personal injury expertise.
Mr. Braly, honored for his asbestos, mesothelioma and product liability practice, secured multiple high-dollar verdicts in 2024, including a
Mr. Linder recently joined the firm. His practice involves toxic tort, product liability, personal injury litigation and appellate matters. He was recently involved in the first-ever verdict in a talc pleurodesis case in
In 2024, the firm secured at least a half-dozen multimillion-dollar judgments for plaintiffs.
Honorees for Lawdragon’s 500 Leading Plaintiff Consumer Lawyers are selected through journalistic reporting and research. View the full list here.
About Dean Omar Branham Shirley
Dean Omar Branham Shirley, LLP, is a nationally recognized trial firm that handles cases across the country for individuals who have suffered catastrophic injuries or have died as a result of irresponsible conduct of others. For more information, please visit http://www.dobslegal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310833863/en/
BeLynn Hollers
800-559-4534
belynn@androvett.com
Source: Dean Omar Branham Shirley, LLP
FAQ
What was the verdict amount in the Johnson & Johnson (JNJ) mesothelioma case won by Dean Omar Branham Shirley?
How many multimillion-dollar judgments did Dean Omar Branham Shirley secure in 2024?
What was the verdict amount in the first-ever talc pleurodesis case in Massachusetts involving JNJ?
How many Dean Omar Branham Shirley partners were named to Lawdragon's 500 Leading Plaintiff Consumer Lawyers for 2025?
